Site icon Dr.Vanta

February 2020 MS News- The Benefits of Dietary Compounds, Vitamin D, NAC, Melatonin, Medical Cannabis, Exercise,Benson Techniques and More

Diet & Supplements

Exercise, electrostimulation and more 

Meditation, relaxation techniques,  and spirituality 

The association between MS and other conditions

Drugs

Prescription Sativex (cannabis- based drug) used as an add on therapy consistently relieves spasticity  and pain associated with spasticity in individuals with MS, according to this new study (randomized controlled trial) 

A Phase I randomized trial of liothyronine for remyelination in MS  was published this month. Liothyronine (L-T3) is a short-acting thyroid hormone and this study assessed safety, tolerability, and optimal dosing of this drug. No serious adverse events were reported with L-T3 over one week, the most common side effects reported were poor sleep and loose stools. 

The impact of the MS drug interferon IFN-beta on pregnancy was evaluated in this new study. Researchers found no evidence that  IFN-beta use before conception and/or during pregnancy would increase the risk for congenital anomalies or spontaneous abortions.

More News & Genetics

This new study reinforces previous studies that found higher levels of aluminum in the brain tissue in those with MS, further suggesting that exposure to aluminum may play a role in the development of MS. 

Vitamin D receptor genetic polymorphisms and the risk of multiple sclerosis. This new systematic review and meta-analysis found FokI polymorphism showed no significant association with MS risk. ApaI and TaqI TT genotype were found contributing to MS susceptibility and BsmI and FokI showed no relation with MS susceptibility.

Exit mobile version